6-(4-hydroxyphenyl)-1-phenyl-2-naphthol

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二芳基庚烷
• 英文名称: 6-(4-hydroxyphenyl)-1-phenyl-2-naphthol
• 英文别名: 6-(4-Hydroxy-phenyl)-1-phenyl-naphthalen-2-ol；6-(4-hydroxyphenyl)-1-phenylnaphthalen-2-ol
• 化学式: C₂₂H₁₆O₂
• 分子量: 312.368
• InChiKey: INNGVLJQICTRAF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.7
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-bromo-2-methoxy-6-(4-methoxyphenyl)naphthalene 在 四(三苯基膦)钯 、 三溴化硼 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 3.0h， 生成 6-(4-hydroxyphenyl)-1-phenyl-2-naphthol
  参考文献：
  名称：

  ERβ Ligands. 3. Exploiting Two Binding Orientations of the 2-Phenylnaphthalene Scaffold To Achieve ERβ Selectivity

  摘要：

  The 2-phenylnaphthalene scaffold was explored as a simplified version of genistein in order to identify ER selective ligands. With the aid of docking studies, positions 1, 4, and 8 of the 2-phenylnaphthalene template were predicted to be the most potentially influential positions to enhance ER selectivity using two different binding orientations. Both orientations have the phenol moiety mimicking the A-ring of genistein. Several compounds predicted to adopt orientations similar to that of genistein when bound to ERbeta were observed to have slightly higher ER affinity and selectivity than genistein. The second orientation we exploited, which was different from that of genistein when bound to ERbeta, resulted in the discovery of several compounds that had superior ER selectivity and affinity versus genistein. X-ray structures of two ER selective compounds (i.e., 15 and 47) confirmed the alternate binding mode and suggested that substituents at positions 1 and 8 were responsible for inducing selectivity. One compound (i.e., 47, WAY-202196) was further examined and found to be effective in two models of inflammation, suggesting that targeting ER may be therapeutically useful in treating certain chronic inflammatory diseases.

  DOI：

  10.1021/jm058173s

文献信息

• Substituted phenyl naphthalenes as estrogenic agents
  申请人：Wyeth

  公开号：US20030181519A1

  公开（公告）日：2003-09-25

  This invention provides estrogen receptor modulators of formula I, having the structure 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 , are as defined in the specification, or a pharmaceutically acceptable salt thereof.

  这项发明提供了具有结构的式I的雌激素受体调节剂 1 其中 R 1 ，R 2 ，R 3 ，R 4 ，R 5 ，R 6 ，R 7 ，R 8 ，R 9 和R 10 如规范中所定义，或其药用可接受盐。
• Modular bismacycles for the selective C–H arylation of phenols and naphthols
  作者：Mark Jurrat、Lorenzo Maggi、William Lewis、Liam T. Ball

  DOI：10.1038/s41557-020-0425-4

  日期：2020.3

  expedient and general strategy for the ortho-arylation of phenols and naphthols using readily available boronic acids. Our methodology relies on in situ generation of a uniquely reactive Bi(V) arylating agent from a bench-stable Bi(III) precursor via telescoped B-to-Bi transmetallation and oxidation. By exploiting reactivity that is orthogonal to conventional metal-catalysed manifolds, diverse aryl and heteroaryl

  鉴于 2-羟基联芳基化合物在有机化学、药物化学和材料化学中的重要作用，合成这种常见基序的简明方法非常有价值。在寻求扩展合成化学家在这方面的词典时，我们开发了一种使用现成的硼酸对苯酚和萘酚进行邻位芳基化的权宜之计和通用策略。我们的方法依赖于通过伸缩的 B 到 Bi 转金属和氧化从工作台稳定的 Bi(III) 前体原位生成独特的反应性 Bi(V) 芳基化剂。通过利用与传统金属催化歧管正交的反应性，多种芳基和杂芳基伙伴可以在温和条件下与苯酚和萘酚快速偶联。芳基化后，Bi（III）前体的高产率回收允许其在后续反应中有效地重复使用。对该方法的每个关键步骤的机械询问为其实际应用提供了信息，并提供了对有机铋化合物未充分利用的反应性的基本见解。
• PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION
  申请人：CHANG Chien-Neng

  公开号：US20090010884A1

  公开（公告）日：2009-01-08

  The present invention provides compositions and methods for preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion using one or more estrogenic agents.

  本发明提供了使用一个或多个雌激素类药物预防、治疗或抑制皮肤炎症性疾病、紊乱或状况以及与胶原蛋白流失相关的疾病、紊乱或状况的组合物和方法。
• Novel uses for estrogen beta agonists
  申请人：Day Mark

  公开号：US20060135574A1

  公开（公告）日：2006-06-22

  This invention provides methods for treating cognitive diseases or disorders and symptoms thereof with estrogen beta selective agonists.

  本发明提供了利用雌激素 beta 选择性激动剂治疗认知疾病或紊乱及其症状的方法。
• SUBSTITUTED PHENYL NAPHTHALENES AS ESTROGENIC AGENTS
  申请人：Wyeth

  公开号：EP1453782A2

  公开（公告）日：2004-09-08